|
Volumn 356, Issue 9232, 2000, Pages 849-850
|
Patents and intellectual property: A salvation for patient-oriented research?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
IMMUNOSUPPRESSIVE AGENT;
KETOCONAZOLE;
SEROTONIN UPTAKE INHIBITOR;
SILDENAFIL;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BIOTECHNOLOGY;
CANCER SUSCEPTIBILITY;
CLINICAL RESEARCH;
DRUG RESEARCH;
ECZEMA;
FINANCIAL MANAGEMENT;
MELANOMA;
PATENT;
PATIENT CARE;
PHOTOTHERAPY;
PRIORITY JOURNAL;
SEBORRHEIC DERMATITIS;
SHORT SURVEY;
SYNDROME DELINEATION;
|
EID: 0034596506
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(00)02666-0 Document Type: Note |
Times cited : (13)
|
References (14)
|